GlassScriptPhysician profile
Brock Booton
NPI 1699194316
$4,537.63
in general payments reported to CMS, 2019-2025
7 companies · $4,028 in 2025
The $4,028 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.02 · 2021: $86.69 · 2022: $191 · 2023: $42.97 · 2024: $94.73 · 2025: $4,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,767 · Food and Beverage: $292 · Entertainment: $87.78 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,766.67 |
| Food and Beverage | $291.56 |
| Entertainment | $87.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $4,230.45 | 2019-2025 | Element Flex, Invisalign |
| Straumann USA LLC | $151.36 | 2023-2025 | |
| Biolase, INC. | $103.93 | 2022 | |
| Implant Direct Sybron International LLC | $14.23 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $13.79 | 2019 | |
| Nobel Biocare USA | $12.82 | 2023 | Nobelactive |
| Ultradent Products INC | $11.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brock Booton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.